April 6, 2009 1:03 PM
- Text
AstraZeneca's "Smoke and Mirrors" Man Has New Job in Medical Writing
(MoneyWatch) Whatever happened to AstraZeneca's "smoke and mirrors" man, Richard Lawrence? You remember him. He was the one who, in 1997, wrote a memo about Seroquel that praised the company's efforts to put a "positive spin" on "this cursed study," and added:
Turns out Lawrence is still in the writing business. He's now the president of Gardiner-Caldwell Communications. Among GGC's services are "Medical Writing and Strategy," including:
Separately, there's an in-depth piece on how AstraZeneca promoted Seroquel in the St. Pete Times today.
I am not 100% comfortable with this data being made publically available at the present time -- however I understand we have little choice -- Lisa has done a great 'smoke-and-mirrors' job!It later emerged that among Seroquel's side effects were weight gain and diabetes.
Turns out Lawrence is still in the writing business. He's now the president of Gardiner-Caldwell Communications. Among GGC's services are "Medical Writing and Strategy," including:
Proven excellence in writing items ranging from sales aids to manuscripts and from Web sites to monographs for the many different healthcare professional and patient audiences.Good luck to him in his new career.
Separately, there's an in-depth piece on how AstraZeneca promoted Seroquel in the St. Pete Times today.
- BNET's previous coverage of AZ and Seroquel:
- AZ Seroquel Trial: Was It "Ghostwriting" or "Professional" Writing?
- AstraZeneca's Seroquel Research Director Confessed to Sex-for-Studies Affairs
- E-Mail: AstraZeneca Knew in 1997 that Seroquel Caused Weight Gain
- Exec Warned AZ on Negative Seroquel Results: "We Cannot Hide Them"; Info Later "Buried"
- AstraZeneca's Sex-for-Studies Seroquel Scandal: Did Research Chief Bias the Science?
- Seroquel Trial: Allegations of Sex-for-Secrets; AZ Wants Papers Sealed
- FDA Asks AZ to Tighten Seroquel Label; 9,000 Lawsuits Start Trials Next Week
- The History of AstraZeneca's Mismarketing of Seroquel
- FDA: J&J's Risperdal and Lilly's Zyprexa Are Over-Used in Kids
- AstraZeneca Allegedly Recruits Tigger and Eeyore to Sell Seroquel
Latest Now in MoneyWatch
- Big banks, gov't officials strike $25B deal
- LinkedIn swings back to profit
- LinkedIn doubles revenue, beats growth estimates
- Kodak to stop making digital cameras, frames
- Market cap, schmarket cap, Apple still gets no respect
- Philip Morris Int'l income up nearly 8 percent
- Survey: Small biz plans big hires in 2012
- Freddie Mac: Mortgages inch higher but stay low
- Will the European debt crisis sink Obama's re-election?
- Banks in $25B deal to settle foreclosure abuses
- Joe Coffee: Scaling up without selling your soul
- Greek agreement accomplishes nothing
- 401K plans: New rules make costs clearer
- Are women leaders selling themselves short?
- Ask the Experts: New 401(k) rules
- Mortgage lenders strike a deal
- $25B foreclosure-abuse settlement reached
Latest CBS News Headlines
on Facebook
on CBS News
- Owner of Sierra mine surrenders to face charges
- Asia stocks slip as Greek bailout remains in limbo
- China trade falls amid weak demand, holiday
- Obama tells gay donors more work to be done
on Facebook
- Adele opens up about vocal cord surgery
- Tenn. father charged with murdering couple who"unfriended" daughter on Facebook
- Mo. teen gets life in prison for murder of 9-year-old girl
on CBS News






